Back

Impact of colchicine on long-term outcomes in patients with intermediate coronary stenosis deferred from pci after ifr assessment: a three-year prospective study

30 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Inflammation and immunity: long-term and myocardial infarction Inflammation and Immunity ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Sherzod Akhmedov

Cardiology Center of Uzbekistan, Tashkent (Uzbekistan)

7 More presentations in this session

Presentation thumbnail
Clinical outcome predicted by coronary flow reserve in patients with a prior myocardial infarction
Miss K. Torngren (Lund, SE)
Abstract
Presentation thumbnail
Novel cardiometabolic indices and coronary microvascular dysfunction in intermediate stenosis: the role of AIP and TyG index
Doctor D. Wu (Beijing, CN)
Abstract
Presentation thumbnail
Long-term cytotoxic skewing of CD4⁺CD8⁺ T cells after STEMI: association with immune senescence in COVID-19 patients
Professor A. Parkhomenko (Kyiv, UA)
Abstract
Presentation thumbnail
iPSC-derived endothelial cells from ACS patients show mitochondrial dysfunction and premature senescence
Doctor E. Straessler (Berlin, DE)
Abstract
Presentation thumbnail
Transcriptomic profiling identifies tumor necrosis factor receptor-associated factor (TRAF)-5 expression in human atherosclerotic plaques as a predictor of future cardiovascular events
Doctor M. Gissler (Freiburg, DE)
Abstract

Access the full session

Session thumbnail
Inflammation and immunity: long-term and myocardial infarction

The Event

Event poster

ESC Congress 2026

30 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Low-dose colchicine in patients treated with percutaneous coronary interventions for myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)
29 August 2020
thumbnail
Congress Presentation
Prognostic value of peri-coronary adipose tissue attenuation and whole vessel and lesion plaque quantification on Coronary Computed Tomography Angiography
28 August 2020
thumbnail
Congress Presentation
Active-target liposomal drug shows significant atherosclerotic plaque regression effect: a proof-of-concept phase 1b/2a clinical trial
1 September 2025
thumbnail
Congress Presentation
Interference with NLRP3-inflammasome mediated signaling does not reduce myocardial ischemia reperfusion injury in a pig model of myocardial infarction
30 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources